«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

29卷

期数:

2023年04期

页码:

391-397

栏目:

基础医学

出版日期:

2023-07-10

文章信息/Info

Title:

CD24 Regulates acute liver injury through murine hepatic iNKT cells

文章编号:

1006-8147（2023）04-0391-07

作者:

汪河; 海蕾; 张学军

天津医科大学基础医学院免疫学系，天津300070

Author(s):

WANG He; HAI Lei; ZHANG Xue-jun

Department of Immunology，School of Basic Medical Sciences，Tianjin Medical University，Tianjin 300070，China

关键词:

CD24分子; α-GalCer; iNKT细胞; 肝损伤

Keywords:

CD24 molecules; α-GalCer; iNKT; liver injury

分类号:

R392.1

DOI:

-

文献标志码:

A

摘要:

目的：探讨小鼠急性肝损伤中CD24分子对不变的自然杀伤T（iNKT）细胞的调控作用。方法：小鼠腹腔注射α-半乳糖甘油酰胺（α-GalCer）特异活化iNKT细胞，诱导小鼠急性肝损伤。HE染色观察小鼠肝脏炎症损伤程度，血清学方法检测转氨酶变化，免疫荧光染色观察肝内iNKT细胞的数量变化，流式细胞术检测肝内总iNKT细胞、iNKT细胞亚型数量、比例及iNKT细胞活性的变化，定量-PCR（Q-PCR）检测肝组织中iNKT细胞相关细胞因子干扰素-γ（IFN-γ）和白细胞介素-4（IL-4）的表达。结果：注射α-GalCer后，CD24基因敲除（CD24-/-）小鼠肝脏炎性细胞浸润比野生型（WT）小鼠少（F=10.10，P<0.01），血清谷丙转氨酶（ALT）水平比WT小鼠低（F=10.11，P<0.01）。免疫荧光染色结果表明，正常生理状态及α-GalCer模型中，CD24-/-小鼠肝内iNKT细胞数量显著低于WT小鼠（F=13.27，P<0.01）。流式细胞术分析发现，正常生理状态下，CD24-/-小鼠肝内总iNKT细胞和其亚型的数量显著低于WT小鼠（F=6.841，P<0.05）；注射α-GalCer后，小鼠肝内总iNKT细胞数量显著增多（F=33.01，P<0.001）；进一步分析iNKT细胞亚型发现，NKT1、NKT2细胞数明显增多（F=37.12、40.55，均P<0.05），但CD24-/-小鼠仍低于WT小鼠（F=40.07、12.53，均P<0.05），NKT17细胞无变化（P＞0.05）。Q-PCR结果表明，注射α-GalCer后，CD24-/-小鼠肝组织中IFN-γ和IL-4mRNA表达水平明显低于WT小鼠（F=14.34、19.77，均P<0.01），流式细胞术检测胞内细胞因子结果表明，α-GalCer模型中，CD24-/-小鼠iNKT细胞分泌的IFN-γ和IL-4明显低于WT小鼠（F=25.600、5.574，均P<0.05）。结论：肝内iNKT细胞与小鼠急性肝损伤密切相关，CD24分子可以通过调节肝内iNKT细胞的数量和活性影响急性肝损伤进程。

Abstract:

Objective：To investigate the regulation of CD24 on invariant NKT cells （ iNKT）in murine acute liver injury. Methods ：In－traperitoneal injection of α-galactosylceramide（ α-GalCer） was used to activate hepatic iNKT cells and induce acute liver injury in mice. Levels of alanine amino transferase （ ALT） in serum were detected and liver sections were stained with hematoxylin and eosin（ HE） staining to assess the severity of liver injury. Changes of the number of iNKT cells in the liver were observed by immune-fluorescence staining.Flow cytometric analysis was used to detect the changes of the number and proportion of total iNKT cells，subtypes and iNKT cells activity in the liver. Q-PCR was used to detect the expression of iNKT cell-related cytokines including interferon-γ （ IFN-γ） and interleukin-4（ IL-4） in mice liver tissues. Results：After injection of α-GalCer，CD24 knockout（ CD24-/-） mice had less hepatic inflammatory cell infiltration and lower serum ALT levels when compared with wild-type（ WT） mice（ F=10.10，10.11，both P<0.01）. Immune-fluorescence staining results showed that the number of intrahepatic iNKT cells was significantly lower in CD24-/-mice than in WT mice in the normal physiological state or in the α-GalCer induced acute liver injury model （ F=13.27，P<0.01）. Flow cytometry analysis showed that the number of total iNKT and subtypes in the liver of CD24-/-mice was lower than that of WT mice under normal physiological conditions（ F=6.841，P<0.05）. After α-GalCer injection，the total number of iNKT cells in the liver of mice was signifi－cantly increased （ F=33.01，P<0.001）.Further analysis of iNKT cell subtypes showed that α-GalCer injection significantly increased the numbers of NKT1 and NKT2 cells（ F=37.12，40.55，both P<0.05），but CD24-/-mice remained lower than WT mice（ F=40.07，12.53，both P<0.05），and NKT17 cells were unchanged（ P>0.05）. Q-PCR showed that the expression levels of IFN-γ and IL-4 mRNA were significantly lower in the liver tissues of CD24-/-mice than WT mice after α-GalCer injection（ F=14.37，19.77，both P<0.01）. Flow cytometry analysis showed that the secretion of IFN-γ and IL-4 were significantly lower in iNKT cells of CD24-/-mice when compared with WT mice in α-GalCer induced liver injury model（ F=25.600，5.574，both P<0.05）. Conclusion：iNKT cells in the liver are closely related to acute liver injury in mice，CD24 can affect the process of acute liver injury in mice by regulating the number and activi－ty of hepatic iNKT cells.

参考文献/References:

[1] RANGASWAMY C，MAILER R K，ENGLERT H，et al. The contact system inliver injury[J]. Semin Immunopathol，2021，43（4）：507-517.
[2] STRAVITZ R T，LEE W M. Acute liver failure[J]. Lancet，2019，394 （ 10201）：869-881.
[3] XU L，YANG Y，WEN Y，et al. Hepatic recruitment of eosinophils and their protective function during acute liver injury[J]. J Hepatol， 2022，77（ 2）：344-352.
[4] BANDYOPADHYAY K，MARRERO I，KUMAR V. NKT cell subsets as key participants in liver physiology and pathology[J]. Cell Mol Immunol，2016，13（ 3）：337-346.
[5] LIU H，HAI L，TIAN J，et al. Anti-CD24 neutralizing antibody ex－acerbates Concanavalin A-induced acute liver injury in mice via liver M1 macrophages[J]. Immunol Lett，2017，181：87-93.
[6] TANG W，ZHOU J，YANG W，et al. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver[J]. Cell Mol Immunol，2022， 19（ 7）：834-847.
[7] MARRERO I，MARICIC I，FELDSTEIN A E，et al. Complex network of NKT cell subsets controls immune homeostasis in liver and gut[J].Front Immunol，2018，9：2082.
[8] WANG Y，ZHANG C. The roles of liver-resident lymphocytes in liv－er diseases[J]. Front Immunol，2019，10：1582.
[9] CHEN Y，TIAN Z. Innate lymphocytes：pathogenesis and therapeutic targets of liver diseases and cancer[J]. Cell Mol Immunol，2021， 18（ 1）：57-72.
[10] SEINO K，TANIGUCHI M. Functionally distinct NKT cell subsets and subtypes [J]. J Exp Med，2005，202（ 12）：1623-1626.
[11] PAUL S，CHHATAR S，MISHRA A，et al. Natural killer T cell acti－vation increases iNOS（+）CD206（-） M1 macrophage and controls the growth of solid tumor[J]. J Immunother Cancer，2019，7（ 1）：208.
[12] NELSON A，GEBREMESKEL S，LICHTY B D，et al. Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regres－sion[J]. J Immunother Cancer，2022，10（ 3）：e003923.
[13] BIBURGER M，TIEGS G. Activation-induced NKT cell hypore－sponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors[J]. J Leukoc Biol，2008， 84（ 1）：264-279.
[14] UMESHAPPA C S，SOLE P，YAMANOUCHI J，et al. Re-program－ming mouse liver-resident invariant natural killer T cells for sup－pressing hepatic and diabetogenic autoimmunity [J]. Nat Commun， 2022，13（ 1）：3279.
[15] ALTEVOGT P，SAMMAR M，HUSER L，et al. Novel insights into the function of CD24：a driving force in cancer[J]. Int J Cancer， 2021，148（ 3）：546-559.
[16] LI D，HU M，LIU Y，et al. CD24-p53 axis suppresses diethylni－trosamine-induced hepatocellular carcinogenesis by sustaining in－trahepatic macrophages[J]. Cell Discov，2018，4：6.
[17] BAI X F，LI O，ZHOU Q，et al. CD24 controls expansion and persis－tence of autoreactive T cells in the central nervous system during ex－perimental autoimmune encephalomyelitis[J]. J Exp Med，2004，200 （ 4）：447-458.
[18] CHEN G Y，TANG J，ZHENG P，et al. CD24 and Siglec-10 selec－tively repress tissue damage-induced immune responses[J]. Science， 2009，323（ 5922）：1722-1725.
[19] CROSBY C M，KRONENBERG M. Tissue-specific functions of in－variant natural killer T cells [J]. Nat Rev Immunol，2018，18（ 9）：559-574.
[20] SANTODOMINGO-GARZON T，SWAIN M G. Role of NKT cells in autoimmune liver disease[J]. Autoimmun Rev，2011，10（ 12）：793-800.
[21] TAKEDA K，HAYAKAWA Y，VAN KAER L，et al. Critical contri－bution of liver natural killer T cells to a murine model of hepatitis[J]. Proc Natl Acad Sci U S A，2000，97（ 10）：5498-5503.
[22] LEE Y J，WANG H，STARRETT G J，et al. Tissue-specific distribu－tion of iNKT cells impacts their cytokine response[J]. Immunity，2015， 43（ 3）：566-578.
[23] LIEW P X，LEE W Y，KUBES P. iNKT cells orchestrate a switch from inflammation to resolution of sterile liver injury[J]. Immunity， 2017，47（ 4）：752-765
[24] LEINWAND J C，PAUL B，CHEN R，et al. Intrahepatic microbes govern liver immunity by programming NKT cells[J]. J Clin Invest， 2022，132（ 8）：e151725.
[25] GAPIN L. Development of invariant natural killer T cells[J]. Curr Opin Immunol，2016，39：68-74.
[26] KAY R，TAKEI F，HUMPHRIES R K. Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens[J]. J Immunol，1990， 145（ 6）：1952-1959.
[27] PEI Z，ZHU G，HUO X，et al. CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro[J]. Oncol Rep， 2016，35（ 3）：1593-1601.
[28] BENDELAC A，SAVAGE P B，TEYTON L. The biology of NKT cells [J]. Annu Rev Immunol，2007，25：297-336.
[29] BARRAL P，POLZELLA P，BRUCKBAUER A，et al. CD169 （+） macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes [J]. Nat Immunol，2010，11（ 4）：303-312.
[30] SCHMIEG J，YANG G，FRANCK R W，et al. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion [J]. Proc Natl Acad Sci U S A，2005，102（ 4）：1127-1132.

相似文献/References:

备注/Memo

备注/Memo:

基金项目: 国家自然科学基金面上项目（31370891）；天津市自然科学基金重点项目（18JCZDJC98300）
作者简介:汪河（1997-），女，硕士在读，研究方向：肝脏炎症与免疫；
通信作者：张学军，E-mail：xjzh@tmu.edu.cn。

常用功能

更新日期/Last Update: 2023-07-10